Ken Greenberg is a Partner at Venrock where he invests in life sciences, biotech, and medical devices. He focuses on healthcare, biotechnology, and pharmaceuticals across the United States (including California and New York) and internationally (Shanghai, British Columbia, and the Nordic countries), and invests from early stage through late stage, including Series B, Series C, and post-IPO equity. He has invested in companies like CytomX Therapeutics, Lycia Therapeutics, Century Therapeutics, Lyra Therapeutics, and Astria Therapeutics.
Previously, he was a Portfolio Manager at Citadel; Therapeutics Sector Head at Ghost Tree Capital; Analyst at Diamondback Capital; Principal at MPM Capital; Associate at McKinsey & Company; a resident physician at Johns Hopkins Hospital; an Investment Banking Associate at Merrill Lynch & Co.; and a Director at HealthMarket. Ken graduated from The Wharton School and lives in New York City.
Ken Greenberg, Partner @ Venrock. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Ken Greenberg from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Ken
Map your path to Ken instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Ken
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.